|
1
|
Varki A: Sialic acids as ligands in
recognition phenomena. FASEB J. 11:248–255. 1997.PubMed/NCBI
|
|
2
|
Kelm S and Schauer R: Sialic acids in
molecular and cellular interactions. Int Rev Cytol. 175:137–240.
1997. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Altevogt P, Fogel M, Cheingsong-Popov R,
Dennis J, Robinson P and Schirrmacher V: Different patterns of
lectin binding and cell surface sialylation detected on related
high- and low-metastatic tumor lines. Cancer Res. 43:5138–5144.
1983.PubMed/NCBI
|
|
4
|
Yogeeswaran G and Salk PL: Metastatic
potential is positively correlated with cell surface sialylation of
cultured murine tumor cell lines. Science. 212:1514–1516.
1981.PubMed/NCBI
|
|
5
|
Abe M, Suzuki O, Tasaki K, Tominaga K and
Wakasa H: Analysis of lectin binding properties on human Burkitt's
lymphoma cell lines that show high spontaneous metastasis to
distant organs in SCID mice: The binding sites for soybean
agglutinin lectin masked by sialylation are closely associated with
metastatic lymphoma cells. Pathol Int. 46:977–983. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Dennis J, Waller C, Timpl R and
Schirrmacher V: Surface sialic acid reduces attachment of
metastatic tumour cells to collagen type IV and fibronectin.
Nature. 300:274–276. 1982. View
Article : Google Scholar : PubMed/NCBI
|
|
7
|
Suzuki O, Nozawa Y, Kawaguchi T and Abe M:
Phaseolus vulgaris leukoagglutinating lectin-binding
reactivity in human diffuse large B-cell lymphoma and its relevance
to the patient's clinical outcome: Lectin histochemistry and lectin
blot analysis. Pathol Int. 49:874–880. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Suzuki O, Nozawa Y, Kawaguchi T and Abe M:
Alpha-2,6-sialylation of L-PHA reactive oligosaccharides and
expression of N-acetylglucosaminyltransferase V in human diffuse
large B cell lymphoma. Oncol Rep. 10:1759–1764. 2003.PubMed/NCBI
|
|
9
|
Suzuki O, Nozawa Y, Kawaguchi T and Abe M:
UDP-GlcNAc2-epimerase regulates cell surface sialylation and cell
adhesion to extracellular matrix in Burkitt's lymphoma. Int J
Oncol. 20:1005–1011. 2002.PubMed/NCBI
|
|
10
|
Suzuki O, Nozawa Y and Abe M: Sialic acids
linked to glycoconjugates of Fas regulate the caspase-9-dependent
and mitochondria-mediated pathway of Fas-induced apoptosis in
Jurkat T cell lymphoma. Int J Oncol. 23:769–774. 2003.PubMed/NCBI
|
|
11
|
Halaas JL, Moskowitz CH, Horwitz S, et al:
ADR-CHOP-14 in patients with diffuse large B-cell lymphoma:
Feasibility and preliminary efficacy. Leuk Lymphoma. 46:541–547.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Zinzani PL, Gherlinzoni F, Storti S,
Zaccaria A, Pavone E, Moretti L, Gentilini P, Guardigni L, De Renzo
A, Fattori PP, et al: Randomized trial of 8-week versus 12-week
VNCOP-B plus G-CSF regimens as front-line treatment in elderly
aggressive non-Hodgkin's lymphoma patients. Ann Oncol.
13:1364–1369. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Chen GL, Yang L, Rowe TC, Halligan BD,
Tewey KM and Liu LF: Nonintercalative antitumor drugs interfere
with the breakage-reunion reaction of mammalian DNA topoisomerase
II. J Biol Chem. 259:13560–13566. 1984.PubMed/NCBI
|
|
14
|
Burden DA and Osheroff N: Mechanism of
action of eukaryotic topoisomerase II and drugs targeted to the
enzyme. Biochim Biophys Acta. 1400:139–154. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Karpinich NO, Tafani M, Rothman RJ, Russo
MA and Farber JL: The course of etoposide-induced apoptosis from
damage to DNA and p53 activation to mitochondrial release of
cytochrome c. J Biol Chem. 277:16547–16552. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Mizumoto K, Rothman RJ and Farber JL:
Programmed cell death (apoptosis) of mouse fibroblasts is induced
by the topoisomerase II inhibitor etoposide. Mol Pharmacol.
46:890–895. 1994.PubMed/NCBI
|
|
17
|
Ma H, Zhou H, Song X, Shi S, Zhang J and
Jia L: Modification of sialylation is associated with multidrug
resistance in human acute myeloid leukemia. Oncogene. 34:726–740.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Suzuki O, Nozawa Y and Abe M: Regulatory
roles of altered N-and O-glycosylation of CD45 in
galectin-1-induced cell death in human diffuse large B cell
lymphoma. Int J Oncol. 26:1063–1068. 2005.PubMed/NCBI
|
|
19
|
Suzuki O, Nozawa Y and Abe M: The
regulatory roles of cell surface sialylation and N-glycans in human
B cell lymphoma cell adhesion to galectin-1. Int J Oncol.
28:155–160. 2006.PubMed/NCBI
|
|
20
|
Lin CF, Chen CL, Chang WT, Jan MS, Hsu LJ,
Wu RH, Tang MJ, Chang WC and Lin YS: Sequential caspase-2 and
caspase-8 activation upstream of mitochondria during ceramideand
etoposide-induced apoptosis. J Biol Chem. 279:40755–40761. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Boesen-de Cock JG, Tepper AD, de Vries E,
van Blitterswijk WJ and Borst J: Common regulation of apoptosis
signaling induced by CD95 and the DNA-damaging stimuli etoposide
and gamma-radiation downstream from caspase-8 activation. J Biol
Chem. 274:14255–14261. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Chandra D, Choy G, Deng X, Bhatia B,
Daniel P and Tang DG: Association of active caspase 8 with the
mitochondrial membrane during apoptosis : Potential roles in
cleaving mitochondrion-endoplasmic reticulum cross talk in
etoposide-induced cell death. Mol Cell Biol. 24:6592–6607. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Gamen S, Anel A, Perez-Galan P, Lasierra
P, Johnson D, Pineiro A and Naval J: Doxorubicin treatment
activates a Z-VAD-sensitive caspase, which causes deltapsim loss,
caspase-9 activity, and apoptosis in Jurkat cells. Exp Cell Res.
258:223–35. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Scaffidi C, Fulda S, Srinivasan A, Friesen
C, Li F, Tomaselli KJ, Debatin KM, Krammer PH and Peter ME: Two
CD95 (APO-1/Fas) signaling pathways. EMBO J. 17:1675–1687. 1998.
View Article : Google Scholar : PubMed/NCBI
|
